278 related articles for article (PubMed ID: 25204569)
1. Prognostic and biologic significance of DNMT3B expression in older patients with cytogenetically normal primary acute myeloid leukemia.
Niederwieser C; Kohlschmidt J; Volinia S; Whitman SP; Metzeler KH; Eisfeld AK; Maharry K; Yan P; Frankhouser D; Becker H; Schwind S; Carroll AJ; Nicolet D; Mendler JH; Curfman JP; Wu YZ; Baer MR; Powell BL; Kolitz JE; Moore JO; Carter TH; Bundschuh R; Larson RA; Stone RM; Mrózek K; Marcucci G; Bloomfield CD
Leukemia; 2015 Mar; 29(3):567-75. PubMed ID: 25204569
[TBL] [Abstract][Full Text] [Related]
2. BAALC and ERG expression levels are associated with outcome and distinct gene and microRNA expression profiles in older patients with de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.
Schwind S; Marcucci G; Maharry K; Radmacher MD; Mrózek K; Holland KB; Margeson D; Becker H; Whitman SP; Wu YZ; Metzeler KH; Powell BL; Kolitz JE; Carter TH; Moore JO; Baer MR; Carroll AJ; Caligiuri MA; Larson RA; Bloomfield CD
Blood; 2010 Dec; 116(25):5660-9. PubMed ID: 20841507
[TBL] [Abstract][Full Text] [Related]
3. Clinical role of microRNAs in cytogenetically normal acute myeloid leukemia: miR-155 upregulation independently identifies high-risk patients.
Marcucci G; Maharry KS; Metzeler KH; Volinia S; Wu YZ; Mrózek K; Nicolet D; Kohlschmidt J; Whitman SP; Mendler JH; Schwind S; Becker H; Eisfeld AK; Carroll AJ; Powell BL; Kolitz JE; Garzon R; Caligiuri MA; Stone RM; Bloomfield CD
J Clin Oncol; 2013 Jun; 31(17):2086-93. PubMed ID: 23650424
[TBL] [Abstract][Full Text] [Related]
4. Identification of let-7a-2-3p or/and miR-188-5p as prognostic biomarkers in cytogenetically normal acute myeloid leukemia.
Jinlong S; Lin F; Yonghui L; Li Y; Weidong W
PLoS One; 2015; 10(2):e0118099. PubMed ID: 25646775
[TBL] [Abstract][Full Text] [Related]
5. Favorable prognostic impact of NPM1 mutations in older patients with cytogenetically normal de novo acute myeloid leukemia and associated gene- and microRNA-expression signatures: a Cancer and Leukemia Group B study.
Becker H; Marcucci G; Maharry K; Radmacher MD; Mrózek K; Margeson D; Whitman SP; Wu YZ; Schwind S; Paschka P; Powell BL; Carter TH; Kolitz JE; Wetzler M; Carroll AJ; Baer MR; Caligiuri MA; Larson RA; Bloomfield CD
J Clin Oncol; 2010 Feb; 28(4):596-604. PubMed ID: 20026798
[TBL] [Abstract][Full Text] [Related]
6. Age-related prognostic impact of different types of DNMT3A mutations in adults with primary cytogenetically normal acute myeloid leukemia.
Marcucci G; Metzeler KH; Schwind S; Becker H; Maharry K; Mrózek K; Radmacher MD; Kohlschmidt J; Nicolet D; Whitman SP; Wu YZ; Powell BL; Carter TH; Kolitz JE; Wetzler M; Carroll AJ; Baer MR; Moore JO; Caligiuri MA; Larson RA; Bloomfield CD
J Clin Oncol; 2012 Mar; 30(7):742-50. PubMed ID: 22291079
[TBL] [Abstract][Full Text] [Related]
7. FLT3 internal tandem duplication associates with adverse outcome and gene- and microRNA-expression signatures in patients 60 years of age or older with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.
Whitman SP; Maharry K; Radmacher MD; Becker H; Mrózek K; Margeson D; Holland KB; Wu YZ; Schwind S; Metzeler KH; Wen J; Baer MR; Powell BL; Carter TH; Kolitz JE; Wetzler M; Moore JO; Stone RM; Carroll AJ; Larson RA; Caligiuri MA; Marcucci G; Bloomfield CD
Blood; 2010 Nov; 116(18):3622-6. PubMed ID: 20656931
[TBL] [Abstract][Full Text] [Related]
8. A novel miR-375-HOXB3-CDCA3/DNMT3B regulatory circuitry contributes to leukemogenesis in acute myeloid leukemia.
Bi L; Zhou B; Li H; He L; Wang C; Wang Z; Zhu L; Chen M; Gao S
BMC Cancer; 2018 Feb; 18(1):182. PubMed ID: 29439669
[TBL] [Abstract][Full Text] [Related]
9. Prognostic importance of MN1 transcript levels, and biologic insights from MN1-associated gene and microRNA expression signatures in cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study.
Langer C; Marcucci G; Holland KB; Radmacher MD; Maharry K; Paschka P; Whitman SP; Mrózek K; Baldus CD; Vij R; Powell BL; Carroll AJ; Kolitz JE; Caligiuri MA; Larson RA; Bloomfield CD
J Clin Oncol; 2009 Jul; 27(19):3198-204. PubMed ID: 19451432
[TBL] [Abstract][Full Text] [Related]
10. A stem cell-like gene expression signature associates with inferior outcomes and a distinct microRNA expression profile in adults with primary cytogenetically normal acute myeloid leukemia.
Metzeler KH; Maharry K; Kohlschmidt J; Volinia S; Mrózek K; Becker H; Nicolet D; Whitman SP; Mendler JH; Schwind S; Eisfeld AK; Wu YZ; Powell BL; Carter TH; Wetzler M; Kolitz JE; Baer MR; Carroll AJ; Stone RM; Caligiuri MA; Marcucci G; Bloomfield CD
Leukemia; 2013 Oct; 27(10):2023-31. PubMed ID: 23765227
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of expression of a single microRNA, miR-181a, in cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.
Schwind S; Maharry K; Radmacher MD; Mrózek K; Holland KB; Margeson D; Whitman SP; Hickey C; Becker H; Metzeler KH; Paschka P; Baldus CD; Liu S; Garzon R; Powell BL; Kolitz JE; Carroll AJ; Caligiuri MA; Larson RA; Marcucci G; Bloomfield CD
J Clin Oncol; 2010 Dec; 28(36):5257-64. PubMed ID: 21079133
[TBL] [Abstract][Full Text] [Related]
12. Prognostic and Biologic Relevance of Clinically Applicable Long Noncoding RNA Profiling in Older Patients with Cytogenetically Normal Acute Myeloid Leukemia.
Papaioannou D; Nicolet D; Ozer HG; Mrózek K; Volinia S; Fadda P; Carroll AJ; Kohlschmidt J; Kolitz JE; Wang ES; Stone RM; Byrd JC; Garzon R; Bloomfield CD
Mol Cancer Ther; 2019 Aug; 18(8):1451-1459. PubMed ID: 31164409
[TBL] [Abstract][Full Text] [Related]
13. TET2 mutations improve the new European LeukemiaNet risk classification of acute myeloid leukemia: a Cancer and Leukemia Group B study.
Metzeler KH; Maharry K; Radmacher MD; Mrózek K; Margeson D; Becker H; Curfman J; Holland KB; Schwind S; Whitman SP; Wu YZ; Blum W; Powell BL; Carter TH; Wetzler M; Moore JO; Kolitz JE; Baer MR; Carroll AJ; Larson RA; Caligiuri MA; Marcucci G; Bloomfield CD
J Clin Oncol; 2011 Apr; 29(10):1373-81. PubMed ID: 21343549
[TBL] [Abstract][Full Text] [Related]
14.
Zhang TJ; Zhou JD; Zhang W; Lin J; Ma JC; Wen XM; Yuan Q; Li XX; Xu ZJ; Qian J
Clin Epigenetics; 2018; 10():47. PubMed ID: 29643943
[TBL] [Abstract][Full Text] [Related]
15. Expression of myeloperoxidase in acute myeloid leukemia blasts mirrors the distinct DNA methylation pattern involving the downregulation of DNA methyltransferase DNMT3B.
Itonaga H; Imanishi D; Wong YF; Sato S; Ando K; Sawayama Y; Sasaki D; Tsuruda K; Hasegawa H; Imaizumi Y; Taguchi J; Tsushima H; Yoshida S; Fukushima T; Hata T; Moriuchi Y; Yanagihara K; Miyazaki Y
Leukemia; 2014 Jul; 28(7):1459-66. PubMed ID: 24457336
[TBL] [Abstract][Full Text] [Related]
16. Epigenetics meets genetics in acute myeloid leukemia: clinical impact of a novel seven-gene score.
Marcucci G; Yan P; Maharry K; Frankhouser D; Nicolet D; Metzeler KH; Kohlschmidt J; Mrózek K; Wu YZ; Bucci D; Curfman JP; Whitman SP; Eisfeld AK; Mendler JH; Schwind S; Becker H; Bär C; Carroll AJ; Baer MR; Wetzler M; Carter TH; Powell BL; Kolitz JE; Byrd JC; Plass C; Garzon R; Caligiuri MA; Stone RM; Volinia S; Bundschuh R; Bloomfield CD
J Clin Oncol; 2014 Feb; 32(6):548-56. PubMed ID: 24378410
[TBL] [Abstract][Full Text] [Related]
17. Survival differences and associated molecular signatures of DNMT3A-mutant acute myeloid leukemia patients.
Lauber C; Correia N; Trumpp A; Rieger MA; Dolnik A; Bullinger L; Roeder I; Seifert M
Sci Rep; 2020 Jul; 10(1):12761. PubMed ID: 32728112
[TBL] [Abstract][Full Text] [Related]
18. RUNX1 mutations are associated with poor outcome in younger and older patients with cytogenetically normal acute myeloid leukemia and with distinct gene and MicroRNA expression signatures.
Mendler JH; Maharry K; Radmacher MD; Mrózek K; Becker H; Metzeler KH; Schwind S; Whitman SP; Khalife J; Kohlschmidt J; Nicolet D; Powell BL; Carter TH; Wetzler M; Moore JO; Kolitz JE; Baer MR; Carroll AJ; Larson RA; Caligiuri MA; Marcucci G; Bloomfield CD
J Clin Oncol; 2012 Sep; 30(25):3109-18. PubMed ID: 22753902
[TBL] [Abstract][Full Text] [Related]
19. MiR-362-5p as a novel prognostic predictor of cytogenetically normal acute myeloid leukemia.
Ma QL; Wang JH; Yang M; Wang HP; Jin J
J Transl Med; 2018 Mar; 16(1):68. PubMed ID: 29540187
[TBL] [Abstract][Full Text] [Related]
20. Low expression of MN1 associates with better treatment response in older patients with de novo cytogenetically normal acute myeloid leukemia.
Schwind S; Marcucci G; Kohlschmidt J; Radmacher MD; Mrózek K; Maharry K; Becker H; Metzeler KH; Whitman SP; Wu YZ; Powell BL; Baer MR; Kolitz JE; Carroll AJ; Larson RA; Caligiuri MA; Bloomfield CD
Blood; 2011 Oct; 118(15):4188-98. PubMed ID: 21828125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
